Announcements Trials

Browse Landscape

Phase

Status

Completed 19 Recruiting 5 Terminated 4 Unknown 3 Withdrawn 2 No longer available 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Radiotherapy 11 pembrolizumab 10 Nivolumab 10 Doxorubicin 10 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Ipilimumab 7 Cyclophosphamide 7 Biopsy 7 X-Rays 6 Radiation 5 Phantoms, Imaging 5 Ifosfamide 5 talimogene laherparepvec 4 cabozantinib 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 tazemetostat 3 selpercatinib 3 pazopanib 3 liposomal doxorubicin 3 Temozolomide 3 Etoposide 3 ulixertinib 2 tislelizumab 2 tipifarnib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sarcoma × Trabectedin × Clear all

NCT06263231 2025-07-29

INVINCIBLE-3

Intensity Therapeutics, Inc.

Phase 3 Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡